Nicheloom

Market intelligence for builders — see what's gaining traction before it's crowded.

Gamgee: Personalised mRNA cancer vaccines for dogs

Input the tumour. Output the vaccine. 300+ dogs on the waitlist.

Details

External ID
109527
Source
YC
Company
Gamgee
Product
Gamgee: Personalised mRNA cancer vaccines for dogs
Website domain
gamgee.io
Launched
Aug. 11, 2026
Cohort
Summer 2026
Upvotes
185
Upvotes percentile
0.9712643678160919
Tags
Biotech, Genomics, Oncology, AI
Fetched at
Sept. 30, 2026, 5 p.m.
Updated at
Sept. 30, 2026, 5 p.m.

Enrichment

Theme
pet tech and virtual companions
Vertical
Healthcare
Function
Vertical SaaS
Audience
B2B
AI stance
AI-native
Project type
Commercial product
Normalized one-liner
personalized mrna cancer vaccines for dogs
Manually corrected
False

Could you build this?

No Gamgee is a wet-lab biotechnology venture designing, synthesizing, and testing personalized mRNA cancer vaccines for veterinary oncology.

What it would actually take: Developing personalized mRNA vaccines entails next-generation genomic sequencing of canine tumor biopsies, neoantigen prediction bioinformatics algorithms, in vitro transcription of mRNA molecules, and lipid nanoparticle (LNP) formulation. It requires wet-lab biochemistry facilities, cold-chain logistics, and veterinary clinical trial infrastructure. The company depends on computational biologists, molecular biologists, and licensed veterinary oncologists.

Competitors

Other products that read as similar to this one — 10 launches clear the similarity bar, closest 8 shown.

Attention rank: #1 of 11 (itself plus its competitors, highest first — normalized so YC and Product Hunt are compared fairly).

Launched 7 days after the earliest competitor.

Other launches for this product

Same idea, different domain

Nobody's really built a vertical saas tool for Insurance yet.